Beth Israel Lahey Health CEO on the Value of Investing in Primary Care

Sometimes, it pays to be number two.

Beth Israel Lahey Health has long been the state’s second-largest hospital system, the second biggest employer, the second most in many categories. When compared to Mass General Brigham, owner of Massachusetts’ two biggest hospitals, Beth israel’s place in the pecking order was always clear.

But Mass General Brigham has faced a number of challenges in recent years, from losing its relationship with Dana-Farber Cancer Institute to reporting significant financial losses. These issues have created an opening for Beth Israel Lahey Health to possibly close the gap.

Beth Israel Lahey Health is now investing heavily in areas where Mass General Brigham is struggling. They’ve recently announced a $100 million investment in a new cancer center in Quincy, directly competing with Dana-Farber’s services. They are also expanding their outpatient care network and focusing on attracting top physicians.

“We’re not trying to be Mass General brigham,” said Dr. Bill Bornstein, chief clinical officer at Beth Israel Lahey Health. “We’re trying to be the best health system *for* Massachusetts, and that means being accessible, affordable, and providing high-quality care in the communities where people live.”

This strategy appears to be working. Beth Israel Lahey Health’s financial performance has been strong, and they are gaining market share in several key areas. While Mass General Brigham remains the dominant player, the balance of power in Massachusetts healthcare is beginning to shift. The second-place finisher is making a strong case for becoming number one.